Kelyniam Global, Inc. (KLYG)
OTCMKTS · Delayed Price · Currency is USD
0.1150
-0.0271 (-19.07%)
Dec 15, 2025, 9:49 AM EST
Kelyniam Global Market Cap
Kelyniam Global has a market cap or net worth of $7.15 million as of December 15, 2025. Its market cap has increased by 300.68% in one year.
Market Cap
7.15M
Enterprise Value
n/a
Revenue
2.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.12
Market Cap Chart
Since April 3, 2008, Kelyniam Global's market cap has increased from 5.24M to 7.15M, an increase of 36.36%. That is a compound annual growth rate of 1.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 7.15M | -8.41% |
| Dec 31, 2024 | 7.80M | 327.63% |
| Dec 28, 2023 | 1.83M | -24.53% |
| Dec 27, 2022 | 2.42M | -4.56% |
| Dec 31, 2021 | 2.53M | -37.32% |
| Dec 28, 2020 | 4.04M | 49.66% |
| Dec 17, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 841.30M |
| Glass House Brands | 743.26M |
| Elite Pharmaceuticals | 537.17M |
| CytoDyn | 407.36M |
| Northwest Biotherapeutics | 368.73M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 298.52M |
| Nika Pharmaceuticals | 291.10M |